Institute for Wealth Management’s NanoViricides NNVC Stock Holding History

Institute for Wealth Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14	Buy	+10	New	+$14	﹤0.01%	1761

Other funds holding NNVC

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return

TRUE Private Wealth Advisors Salem, Oregon $1.16B AUM 36.18% 1-Year Est. Return

BankPlus Trust Department Jackson, Mississippi $428M AUM 26.85% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Institute for Wealth Management's NNVC Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in NanoViricides (NNVC) in Q2 2026: 10 shares worth $14. The stake represents ﹤0.01% of the portfolio and ranks #1761 among its holdings.

11 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Institute for Wealth Management held 10 shares of NanoViricides worth $14 as of Q2 2026.
NanoViricides was a new Institute for Wealth Management position in Q2 2026.
NanoViricides made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1761 holding.
11 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.